PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response

Clinical trial NCT00454779 · COMPLETED

Trial details

NCT number: NCT00454779
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck

Start date: 2007-01-01
Primary completion: 2012-06-11
Enrollment: 113

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.